
Company Info
Year Established2018
Contacts
Susan Dillon, Ph.D.,CEO
Karyn O’Neil, PhD
Co-founder & CSO
Mittie Doyle, MD, FACR
CTO
Mark Laurenzi
CAO & CLO
Company Description
Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.